Company news

hVIVO plc news in 2025

hVIVO plc's news releases, calls and decks from 2025, newest first.

View company

Appointment of Non-Executive Director

December 18, 2025

CEO & CFO Share Purchase

December 15, 2025

MSD to acquire Cidara

November 27, 2025

>£5 million CRS contracts signed

November 20, 2025

Positive data from novel human challenge models

November 11, 2025

Holding(s) in Company

November 6, 2025

Presentation at Jefferies Healthcare Conference

November 3, 2025

Interim results

September 23, 2025

Notice of Results

September 4, 2025

Appointment of Non-Executive Chair

September 1, 2025

Proposed appointment of Chair

July 29, 2025

H1 Trading update

July 22, 2025

Directorate Change

July 18, 2025

Positive results from client Phase 2b field study

June 30, 2025

Result of AGM

June 5, 2025

Director/PDMR Shareholding

June 2, 2025

Trading update

May 30, 2025

Appointment of Independent Non-Executive Director

May 29, 2025

Annual Report, Notice of AGM & Directorate Change

May 12, 2025

Exercise of Options

April 10, 2025

Final results

April 10, 2025

AIM Rule 17 and Schedule 2(g) Update

March 26, 2025

Acquisition of Cryostore for up to £3.2m

February 27, 2025

£2m hMPV characterisation study contract

February 17, 2025

Shionogi reports positive RSV trial results

February 5, 2025

RSV contract signed with Inhalon Biopharma

February 3, 2025

Acquisition: two Clinical Research Units from CRS

January 29, 2025

LOI signed for Phase 3 Whooping Cough trial

January 27, 2025

£3.2m hLAB project

January 21, 2025

hMPV challenge model update

January 13, 2025

Calls in 2025

Decks in 2025